1. Home
  2. CLDI vs IBO Comparison

CLDI vs IBO Comparison

Compare CLDI & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • IBO
  • Stock Information
  • Founded
  • CLDI 2014
  • IBO 2018
  • Country
  • CLDI United States
  • IBO United States
  • Employees
  • CLDI N/A
  • IBO N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • IBO
  • Sector
  • CLDI Health Care
  • IBO
  • Exchange
  • CLDI Nasdaq
  • IBO NYSE
  • Market Cap
  • CLDI 18.1M
  • IBO 17.9M
  • IPO Year
  • CLDI N/A
  • IBO 2024
  • Fundamental
  • Price
  • CLDI $0.76
  • IBO $1.56
  • Analyst Decision
  • CLDI Strong Buy
  • IBO
  • Analyst Count
  • CLDI 3
  • IBO 0
  • Target Price
  • CLDI $16.67
  • IBO N/A
  • AVG Volume (30 Days)
  • CLDI 1.2M
  • IBO 24.4K
  • Earning Date
  • CLDI 03-14-2025
  • IBO 02-23-2025
  • Dividend Yield
  • CLDI N/A
  • IBO N/A
  • EPS Growth
  • CLDI N/A
  • IBO N/A
  • EPS
  • CLDI N/A
  • IBO 0.01
  • Revenue
  • CLDI N/A
  • IBO N/A
  • Revenue This Year
  • CLDI N/A
  • IBO N/A
  • Revenue Next Year
  • CLDI N/A
  • IBO N/A
  • P/E Ratio
  • CLDI N/A
  • IBO $122.50
  • Revenue Growth
  • CLDI N/A
  • IBO N/A
  • 52 Week Low
  • CLDI $0.69
  • IBO $1.16
  • 52 Week High
  • CLDI $16.80
  • IBO $3.25
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 29.25
  • IBO N/A
  • Support Level
  • CLDI $0.83
  • IBO N/A
  • Resistance Level
  • CLDI $0.94
  • IBO N/A
  • Average True Range (ATR)
  • CLDI 0.12
  • IBO 0.00
  • MACD
  • CLDI -0.02
  • IBO 0.00
  • Stochastic Oscillator
  • CLDI 9.85
  • IBO 0.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Share on Social Networks: